Professor A. Ian Scott, an internationally acclaimed and pioneering chemist, came to Texas A&M University in 1977 and achieved worldwide renown for his work with vitamin B12, the essential life pigments chlorophyll and heme, the cancer drug taxol, and other important natural products. He was one of the early US chemists to apply the concepts and methodologies of chemistry to the study of biological systems and his research revolutionized both organic and natural products chemistry.
We celebrate the tremendous scientific contributions Scott made during his 30-year-Texas A&M career, both to the University and to the international chemistry community, with the A. I. Scott Medal for Excellence in Biological Chemistry Symposium on September 27-28, 2019. Professor Benjamin Cravatt is the 2019 medalist.
Dr. Peter G. Schultz has made many seminal contributions to the fields of chemical and synthetic biology, including the development and application of methods to expand the genetic code of living organisms, the discovery of catalytic antibodies, and the development and application of molecular diversity technologies to address problems in chemistry, materials science, and medicine. He earned his undergraduate (summa cum laude) and doctoral degrees at the California Institute of Technology. After postdoctoral studies at the Massachusetts Institute of Technology, Schultz joined the faculty at the University of California, Berkeley in 1985, where he was a chemistry professor, a principal investigator at Lawrence Berkeley National Laboratory and a Howard Hughes Medical Institute Investigator. He joined Scripps Research in 1999 and was appointed chief executive officer in 2015. The following year, he was named president of the institute.
Schultz has founded nine biotech/tech companies that have pioneered the development and application of new technologies to challenges in human health and materials science. In 1999, he founded the Genomics Institute of the Novartis Research Foundation, serving as its director for more than 10 years. In 2012, he established CALIBR, a nonprofit biomedical research institute designed as a new model to accelerate the discovery of innovative medicines that is now an operating division of Scripps Research.
An elected member of the National Academy of Sciences, National Academy of Medicine, and American Academy of Arts and Sciences, Schultz has co-authored more than 600 scientific publications and is active on many editorial and scientific advisory boards. He has trained in excess of 300 graduate students and postdoctoral fellows, many of whom are on the faculties of major research institutions around the world. Schultz has received numerous prestigious awards, including the Wolf Prize in Chemistry, the National Science Foundation's Alan T. Waterman Award, the Solvay Prize, the Paul Ehrlich and Ludwig Darmstaedter Prize, the American Chemical Society's Arthur C. Cope Award, the Heinrich Wieland Prize, and the NAS Award in Chemical Sciences.
|1:00 pm||Poster Session|
|1:50 pm||Opening Remarks, Simon North and Tadhg Begley, Texas A&M University|
|2:00 pm||Kevan Shokat, University of California, San Francisco "Drugging Undruggable Targets in Oncology Through New Covalent Chemistry"|
|3:00 pm||Linda Hsieh-Wilson, California Institute of Technology "Harnessing Glycans and Chemistry to Understand Neuroplasticity"|
|4:00 pm||Poster Session and Coffee Break|
|4:30 pm||Peter G. Schultz, Scripps Research, 2019 Scott Medalist "Playing With the Molecules of Life"|
|8:15 pm||Presentation of the AI Scott Medal
Daniel Tabor, Chair, Texas A&M Section of the American Chemical Society
Professor Peter Schultz
|9:00 am - 5:00 pm||Biological Chemistry Research Symposium
This symposium will feature invited talks on current biological chemistry research by Texas A&M graduate students and postdocs and will begin with a plenary lecture given by Professor Audrey Lamb of the University of Texas, San Antonio. The title of Dr. Lamb's lecture is "Evidence for the chemical mechanism of dihydroxybutanone phosphate (DHBP) synthase from riboflavin biosynthesis".